Su2003 Significance of EMAST/MSI-L and Chromosome 9p24.2 Loss of Heterozygosity (LOH) for Patient Survival With Stage II/III Colorectal Cancer (CRC)
Koi M, Garcia M, Choi C, Kim H, Koike J, Hemmi H, Nagasaka T, Okugawa Y, Toiyama Y, Kitajima T, Imaoka H, Kusunoki M, Chen Y, Mukherjee B, Boland C, Carethers J. Su2003 Significance of EMAST/MSI-L and Chromosome 9p24.2 Loss of Heterozygosity (LOH) for Patient Survival With Stage II/III Colorectal Cancer (CRC). Gastroenterology 2016, 150: s607. DOI: 10.1016/s0016-5085(16)32085-6.Peer-Reviewed Original Research